Exhibitions in Bologna, Italy for Health

Bologna’s health industry is shifting focus on the development of advanced medical technologies and personalized medicine. The city finds itself as the home base of numerous startups, which are designing solutions tailored to meet both global and local healthcare challenges. One of the standout innovators in Bologna is Bioverse srl, a startup that is addressing the urgent need for medical devices in emergency settings and low-resource environments. Bioverse is focused on reducing the global healthcare disparity by developing affordable technologies designed specifically for areas with limited resources. Their flagship project, Corax the Life Box, is an innovative device aimed at the treatment of severely burned patients, particularly children with Total Body Surface Area burns exceeding 20%. Another player in Bologna's health industry is Stem Sel, a company that has developed Celector®, a patented cell chromatograph designed for the separation and characterization of living human cells. Celector® is particularly valuable for working with adult stem cells, which often lack reliable markers or functional assays. This ""tagless"" technology enables high-quality control and selection of stem cells from discarded adult tissues such as placenta and umbilical cord blood. The innovation behind Celector® highlights Bologna's growing expertise in the field of regenerative medicine and stem cell research. In the realm of oncology, Cellply is making significant strides with its diagnostic platform that aims to revolutionize personalized cancer treatment. Despite the massive global expenditure on oncology drugs, only a fraction of these therapies benefit patients effectively. Cellply’s technology addresses this gap by providing a platform that assesses the efficacy of cancer drugs beyond genetic profiling, which currently applies to only a small percentage of patients. By focusing on personalized treatment plans, Cellply offers new hope to cancer patients who may not benefit from conventional genetic-based therapies, making it a crucial contributor to the fight against cancer.

Newsletter
Want to stay informed about the latest trade fair and hotel news? Consider signing up for our newsletter.